S Maxion-Bergemann: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

Counterstatement to a FACT Perspective article: ‘A critique of the Swiss report Homeopathy in Healthcare ’

von Ammon, Klaus, Bornhöft, Gudrun, Maxion-Bergemann, Stefanie, Righetti, Marco, Baumgartner, Stephan, Thurneysen, André, Wolf, Ursula, Matthiessen, Peter F

Journal:

Focus on Alternative and Complementary Therapies

Year:

2013

Language:

english

File:

PDF, 143 KB

english, 2013

2

Die Rolle der externen Validität bei der Beurteilung klinischer Studien zur Demenzbehandlung mit Ginkgo-biloba-Extrakten

G. Bornhöft, S. Maxion-Bergemann, P. F. Matthiessen

Journal:

Zeitschrift für Gerontologie und Geriatrie

Year:

2008

Language:

german

File:

PDF, 418 KB

german, 2008

3

Die Rolle der externen Validität bei der Beurteilung klinischer Studien zur Demenzbehandlung mit Ginkgo-biloba-Extrakten

G. Bornhöft, S. Maxion-Bergemann, P. F. Matthiessen

Journal:

Zeitschrift für Gerontologie und Geriatrie

Year:

2008

Language:

german

File:

PDF, 80 KB

german, 2008

4

Update in the pharmaceutical therapy of the irritable bowel syndrome

F. Thielecke, S. Maxion-Bergemann, F. Abel, A-K. Gonschior

Journal:

International Journal of Clinical Practice

Year:

2004

Language:

english

File:

PDF, 137 KB

english, 2004

5

Checklist for the qualitative evaluation of clinical studies with particular focus on external validity and model validity

Gudrun Bornhöft, Stefanie Maxion-Bergemann, Ursula Wolf, Gunver S Kienle, Andreas Michalsen, Horst C Vollmar, Simon Gilbertson, Peter F Matthiessen

Journal:

BMC Medical Research Methodology

Year:

2006

Language:

english

File:

PDF, 338 KB

english, 2006

6

PDB53 INTERNAL VALIDATION OF THE ECONOMIC ASSESSMENT OF GLYCEMIC CONTROL AND LONG-TERM EFFECTS (EAGLE) DIABETES MODEL

S Walzer, S Maxion-Bergemann, R Bergemann, RN Casciano, E Mueller

Journal:

Value in Health

Year:

2005

Language:

english

File:

PDF, 59 KB

english, 2005

7

PCV169 ACETYLSALICYLIC ACID(ASA) MONOTHERAPY FOR SECONDARY PREVENTION OF CARDIOVASCULAR EVENTS IN PATIENTS WITH PERIPHERAL ARTERIAL DISEASE: AN ASSESSMENT OF THE MEDICAL BENEFIT USING THE IQWIG METHODOLOGICAL APPROACH

S Maxion-Bergemann, F Hessel, ES Dietrich

Journal:

Value in Health

Year:

2009

Language:

english

File:

PDF, 71 KB

english, 2009

8

PDB5 LONG-TERM CONSEQUENCES FOR THE TREATMENT OF HYPERTENSIVE DIABETES TYPE 2 PATIENTS WITH A FIXED COMBINATION OF AN ACE-INHIBITOR AND NON-DIHYDROPYRIDINE-CALCIUM-CHANNELBLOCKER IN COMPARISON TO OTHER COMBINATION THERAPIES

S Maxion-Bergemann, W Wittenberg, R Bergemann

Journal:

Value in Health

Year:

2002

Language:

english

File:

PDF, 82 KB

english, 2002

9

PDB1 IMPROVED GLYCAEMIC CONTROL AND LESS HYPOGLYCAEMIA WITH INSULIN GLARGINE COMPARED WITH NPH INSULIN IN PATIENTS WITH TYPE 2 DIABETES LEADS TO FEWER LONG-TERM COMPLICATIONS—RESULTS OF THE DIABETES MELLITUS SIMULATION MODEL

S Maxion-Bergemann, E Müller, R Bergemann, S Walleser, E Huppertz

Journal:

Value in Health

Year:

2003

Language:

english

File:

PDF, 83 KB

english, 2003

10

PDB33 EAGLE—DIABETES MODEL: BASIC FEATURES AND INTERNAL VALIDATION OF SIMULATING LONG-TERM DIABETIC OUTCOMES AND RELATED COSTS

E Mueller, S Maxion-Bergemann, D Gultyaev, S Walzer, R Bergemann

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 62 KB

english, 2004

11

PDB32 LONG-TERM DIABETES COMPLICATIONS: INFLUENCE OF DELAY IN STARTING INTENSIFIED THERAPY AND OF PATIENT RATES TREATED TO TARGET A1C.ANALYSES WITH THE DIABETES MELLITUS MODEL (DMM)

R Bergemann, E Huppertz, E Mueller, S Maxion-Bergemann

Journal:

Value in Health

Year:

2004

Language:

english

File:

PDF, 62 KB

english, 2004

12

International Variation in Resource Utilisation and Treatment Costs for Rheumatoid Arthritis

Rosery, Hubertus, Bergemann, Rito, Maxion-Bergemann, Stefanie

Journal:

PharmacoEconomics

Year:

2005

Language:

english

File:

PDF, 141 KB

english, 2005

13

Prediction of acute and chronic complications by a new computer simulation model for type 1 and type 2 diabetes: the Diabetes Mel l it us Model (DMM)

Bergemann, Rito, Hauner, Hans, Morris, Andrew D, Dinneen, Sean F, Suissa, Samy, Gultyaev, Dmitry, Maxion-Bergemann, Stefanie, Müller, Elvira

Journal:

Journal of Medical Economics

Year:

2006

Language:

english

File:

PDF, 368 KB

english, 2006

14

Costs of irritable bowel syndrome in the UK and US

Stefanie Maxion-Bergemann,Frank Thielecke,Florian Abel…

Journal:

PharmacoEconomics

Year:

2006

Language:

english

File:

PDF, 161 KB

english, 2006

15

Diabetes Mel l it us Model (DMM): internal validation of a computer simulation model for type 1 and type 2 diabetes

Maxion-Bergemann, Stefanie, Walleser, Silke, Müller, Elvira, Dinneen, Sean F, Suissa, Samy, Hauner, Hans, Morris, Andrew D, Bergemann, Rito

Journal:

Journal of Medical Economics

Year:

2006

Language:

english

File:

PDF, 288 KB

english, 2006

16

Development and Validation of the Economic Assessment of Glycemic Control and Long-Term Effects of Diabetes (EAGLE) Model

Mueller, Elvira, Maxion-Bergemann, Stefanie, Gultyaev, Dmitry, Walzer, Stefan, Freemantle, Nick, Mathieu, Chantal, Bolinder, Bjorn, Gerber, Robert, Kvasz, Marion, Bergemann, Rito

Journal:

Diabetes Technology & Therapeutics

Year:

2006

Language:

english

File:

PDF, 128 KB

english, 2006

17

Complementary and Alternative Medicine Costs – a Systematic Literature Review

Maxion-Bergemann, Stefanie, Wolf, Martin, Bornhöft, Gudrun, Matthiessen, Peter F., Wolf, Ursula

Journal:

Forschende Komplementärmedizin / Research in Complementary Medicine

Year:

2006

File:

PDF, 50 KB

2006

18

Traditional Chinese Medicine (Phytotherapy): Health Technology Assessment Report – Selected Aspects

Maxion-Bergemann, Stefanie, Bornhöft, Gudrun, Sonderegger, Emanuel, Renfer, Adrian, Matthiessen, Peter F., Wolf, Ursula

Journal:

Forschende Komplementärmedizin / Research in Complementary Medicine

Year:

2006

File:

PDF, 104 KB

2006

19

DMP Diabetes mellitus: Simulationder Behandlungsergebnisse verschiedener Leitlinien

H. Hauner, S. Maxion-bergemann, E. Müller, M. Schulz, E. Huppertz, R. Bergemann

Year:

2003

File:

PDF, 151 KB

2003

20

Use of Complementary Medicine in Switzerland

Wolf, Ursula, Maxion-Bergemann, Stefanie, Bornhöft, Gudrun, Matthiessen, Peter F., Wolf, Martin

Journal:

Forschende Komplementärmedizin / Research in Complementary Medicine

Year:

2006

File:

PDF, 55 KB

2006

21

Epidemiology of Multiple Sclerosis: Literature Review for Prevalence and Trend Over Time in 5 European Countries and Canada

Maxion-Bergemann, S, Windisch, R

Journal:

Value in Health

Year:

2017

Language:

english

File:

PDF, 60 KB

english, 2017